Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|31|3413-3417

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.31, 2011-10, pp. : 3413-3417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAP (Davunetide) Provides Functional and Structural Neuroprotection

By  

Current Pharmaceutical Design, Vol. 17, Iss. 10, 2011-04 ,pp. : 1040-1044

Bentham Science Publishers

Access to resources Recommend Favorite

The Immunoproteasome: An Emerging Therapeutic Target

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2923-2930

Bentham Science Publishers

Access to resources Recommend Favorite

Tau Protein Phosphorylation as a Therapeutic Target in Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 727-740

Bentham Science Publishers

Access to resources Recommend Favorite

Davunetide: Peptide Therapeutic in Neurological Disorders

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2591-2598

Bentham Science Publishers

Access to resources Recommend Favorite